Fermented or unfermented milk using Bifidobacterium animalis subsp. lactis HN019: Technological approach determines the probiotic modulation of mucosal cellular immunity

Food Research International

Volumn 64, Issue , 2014, Pages 283-288

  Bogsan, C S B ^a   Ferreira, L ^a   Maldonado, C ^b   Perdigon, G ^b   Almeida, S R ^a   Oliveira, M N ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

Author keywords

B1 cells; Bifidobacterium animalis subsp. lactis HN019; Fermented milk; Immunomodulation; Matrix probiotic mucosa interaction

Indexed keywords

BACTERIA; FERMENTATION; MAMMALS;

BENEFICIAL EFFECTS; BIFIDOBACTERIUM ANIMALIS; FERMENTATION PROCESS; IMMUNO MODULATIONS; INTESTINAL CELLS; MATRIX-PROBIOTIC-MUCOSA INTERACTION; METABOLIC ACTIVITY; PATHOGENIC SPECIES; PROBIOTICS;

FERMENTED MILK;

EID: 84904295431     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2014.05.036     Document Type: Article

References (34)

1. Acheson D.W.K., Luccioli S. Mucosal immune responses. Best Practice and Research. Clinical Gastroenterology 2004, 18(2):387-404.
2. Baumgarth N. The double life of a B-1 cell: Self-reactivity selects for protective effector functions. Nature Reviews. Immunology 2011, 11(1):34-46.
3. Bogsan C.S.B., Florence A.C.R., Perina N., Hirota C., Soares F.A.S.M., Silva R.C., et al. Survival of Bifidobacterium lactis HN019 and release of biogenic compounds in unfermented and fermented milk is affected by chilled storage at 4°C. Journal of Probiotics and Health 2013, 4(1).
4. Candela M., Biagi E., Turroni S., Vitali B., Brigidi P. Mechanisms involved in the intestinal interaction between host and bifidobacteria. Microbial Ecology in Health and Disease 2008, 20(4):189-192.
5. Castillo N.A., de Moreno de Le Blanc A., Galdeano C.M., Perdigón G. Probiotics: An alternative strategy for combating salmonellosis: Immune mechanisms involved. Food Research International 2012, 45:831-841.
6. Collado M.C., Isolauri E., Salminen S., Sanz Y. The impact of probiotic on gut metabolism. Current Drug Metabolism 2009, 10(1):68-78.
7. De Moreno De Leblanc A.D., Chaves S., Carmuega E., Weill R., Antoine J., Perdigon G. Effect of long-term continuous consumption of fermented milk containing probiotic bacteria on mucosal immunity and the activity of peritoneal macrophages. Immunobiology 2008, 213(2):97-108.
8. FAO/WHO Guidelines for the evaluation of probiotics in food: Report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food 2002, FAO/WHO, London.
9. Galdeano C.M., de Le Blanc A.D., Vinderola G., Bonet A.E.B., Perdigon G. Proposed model: Mechanisms of immunomodulation induced by probiotic bacteria. Clinical and Vaccine Immunology 2007, 14(5):485-492.
10. Galdeano C.M., Perdigon G. Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation. Journal of Applied Microbiology 2004, 97(4):673-681.
11. Gill H.S., Rutherfurd K.J. Immune enhancement conferred by oral delivery of Lactobacillus rhamnosus HN001 in different milk-based substrates. Journal of Dairy Research 2001, 68(4):611-616.
12. Gogineni V.K., Morrow L.E., Malesker M.A. Probiotics: Mechanisms of action and clinical applications. Journal of Probiotics and Health 2013, 1:101.
13. Gopal P.K., Prasad J., Gil H.S. Effects of the consumption of Bifidobacterium lactis HN019 (DR10TM) and galacto-oligosaccharides on the microflora of the gastrointestinal tract in human subjects. Nutrition Research 2003, 1313-1328.
14. Grzeskowiak L., Isolauri E., Salminen S., Gueimonde M. Manufacturing process influences properties of probiotic bacteria. British Journal of Nutrition 2011, 105(6):887-894.
15. Hardy H., Harris J., Lyon E., Beal J., Foey A.D. Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients 2013, 5:1869-1912.
16. Herzenberg L.A., Tung J., Moore W.A., Herzenberg L.A., Parks D.R. Interpreting flow cytometry data: A guide for the perplexed. Nature Immunology 2006, 7(7):685.
17. Macpherson A.J., Geuking M.B., McCoy K.D. Immunoglobulin A: A bridge between innate and adaptive immunity. Current Opinion in Gastroenterology 2011, 27(6):529-533.
18. Macpherson A.J., Harris N.L. Interactions between commensal intestinal bacteria and the immune system. Nature Reviews. Immunology 2004, 4(6):478-485.
19. Macpherson A.J., Uhr T. Compartmentalization of the mucosal immune responses to commensal intestinal bacteria. Oral Tolerance: New Insights and Prospects for Clinical Application 2004, 1029:36-43.
20. + T-cell activation. European Journal of Immunology 2013, 43(9):2317-2326.
21. Matsumoto M., Ishige A., Yazawa Y., Kondo M., Muramatsu K., Watanabe K. Promotion of intestinal peristalsis by Bifidobacterium spp. capable of hydrolysing sennosides in mice. PloS One 2012, 7(2). (art.no. e31700).
22. Mazmanian S.K., Liu C.H., Tzianabos A.O., Kasper D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
23. Mileti E., Matteoli G., Iliev I.D., Rescigno M. Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PloS One 2009, 4(9):e7056.
24. Nilsson A.C., Stman E.M.O., Holst J.J., Björck I.M.E. Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. The Journal of Nutrition and Disease 2008, 138:732-739.
25. Ouwehand A.C., Bergsma N., Parhiala R., Lahtinen S., Gueimonde M., Finne-Soveri H., et al. Bifidobacterium microbiota and parameters of immune function in elderly subjects. FEMS Immunology and Medical Microbiology 2008, 53(1):18-25.
26. Pabst O. Regulation of immune cell exit from the intestine. International Congress of Mucosal Immunology, ICMI 16th, Vancouver, Canadá 2013.
27. Perdigon G., Galdeano C.M., Valdez J.C., Medici M. Interaction of lactic acid bacteria with the gut immune system. European Journal of Clinical Nutrition 2002, 56:S21-S26.
28. Ranadheera R.D.C.S., Baines S.K., Adams M.C. Importance of food in probiotic efficacy. Food Research International 2010, 43:1-7.
29. Sánchez B., Reyes-Gavila C.G., Margolles A., Gueimonde M. Probiotic fermented milks: Present and future. International Journal of Dairy Technology 2009, 62(4):472-483.
30. Spinnler H.E., Corrieu G. Automatic method to quantify starter activity based on pH measurement. Journal of Dairy Research 1989, 56:755-764.
31. Van Kruiningen H.J., West A.B., Freda B.J., Holmes K.A. Distribution of Peyer's patches in the distal ileum. Inflammatory Bowel Diseases 2002, 8(3):180-185.
32. Vitiñi E., Alvarez S., Medina M., Medici M., De Budeguer M.V., Perdigon G. Gut mucosal immunostimulation by lactic acid bacteria. Biocell Journal 2000, 24(3):223-232.
33. WGO The functional food revolution; the roles of probiotics and prebiotics in gastroenterology http://www.worldgastroenterology.org/wgo-dvd-nutrition-04.html.
34. Yan F., Polk D.B. Probiotics and immune health. Current Opinion in Gastroenterology 2011, 27(6):496-501.